Insights
23-Nov-17 China Renaissance, a Beijing investment bank and VC investor, plans to expand its operation with an additional USD7 billion to build up its healthcare/biotechnology investments including Huaxing Healthcare, and other sectors. [image: China Renaissance].
Read More
Insights
21-Nov-17 Shanghai Pharmaceuticals has agreed to pay USD557 million for Cardinal Health’s China drug distribution business, growing its nationwide presence and making it a distributor to 322 cities and 11,000 medical institutions. [image: Healthcare Packaging]
Read More
Insights
15-Nov-17 Fortis Healthcare board has approved the proposed acquisition of Singapore based RHT Health Trust for INR4,650 crore (USD720 mn), as part of an effort to consolidate the Indian asset portfolio of clinical establishments and two hospitals into Fortis. [image: ET Healthworld]
Read More
05-Oct-17 Chinese drug firm Fosun Pharma has acquired a 74% controlling interest of Hyderabad based Gland Pharma at a valuation of USD1.1 bn. The new owners intend to keep present management in charge of the day-to-day running of the company. [image: Gland Pharma Limited]
Read More
04-Oct-17 The largest independent health insurance company in India, Chennai based Star Health & Allied Insurance, has formally kicked off a sale process with an asking price of USD900 mn to USD1 bn. [image: ET Healthworld]
Read More